Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE:002773)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Pharmaceutical Manufacturing	4.45B	3.96B	3.39B	3.61B	3.29B
Pharmaceutical Manufacturing Growth	12.49%	16.78%	-6.01%	9.44%	1.13%
Unallocated Other Business	1.49M	626.85K	635.74K	186.83K	1.27M
Unallocated Other Business Growth	137.39%	-1.40%	240.28%	-85.32%	-
Total	4.45B	3.96B	3.39B	3.61B	3.30B
Total Growth	12.51%	16.77%	-6.00%	9.40%	1.17%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Northeast China	300.93M	262.54M	211.53M	218.52M	274.95M
Northeast China Growth	14.62%	24.11%	-3.20%	-20.52%	-9.83%
North China	580.38M	510.03M	412.62M	425.48M	299.33M
North China Growth	13.79%	23.61%	-3.02%	42.15%	-12.45%
East China	1.20B	1.06B	932.25M	1.04B	1.01B
East China Growth	12.74%	14.17%	-10.40%	3.10%	-0.06%
South China	1.13B	985.71M	887.00M	918.75M	818.58M
South China Growth	14.90%	11.13%	-3.46%	12.24%	10.16%
Northwest China	397.36M	363.54M	285.19M	314.24M	294.60M
Northwest China Growth	9.30%	27.47%	-9.25%	6.67%	-0.97%
Southwest China	824.60M	762.71M	653.77M	686.25M	593.78M
Southwest China Growth	8.11%	16.66%	-4.73%	15.57%	6.40%
Overseas	15.29M	7.93M	6.02M	1.42M	3.74M
Overseas Growth	92.97%	31.59%	324.06%	-62.06%	200.73%
Unallocated	1.49M	626.85K	635.74K	186.83K	1.27M
Unallocated Growth	137.39%	-1.40%	240.28%	-85.32%	34.95%
Total	4.45B	3.96B	3.39B	3.61B	3.30B
Total Growth	12.51%	16.77%	-6.00%	9.40%	1.17%

Source: S&P Global Market Intelligence.